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ABSTRACT
Use of induced hypothermia for the purpose of lowering intracranial pressure and
preserving neuronal function has increased as research data reveals a trend of positive outcomes
in patients treated with this therapy. Recently induced hypothermia following cardiac arrest due
to ventricular fibrillation has been deemed successful. Current research has expanded to evaluate
the effectiveness of induced hypothermia as a treatment modality for severe stroke and head
trauma. In spite of its efficacy, complications exist with this treatment modality. The purpose of
this literature review is to examine potential complications secondary to induced hypothermia
and highlight the nurse’s role in managing patient care. At the present, patient protocols for
induced hypothermia are lacking. The success of treatment is largely dependent on the skill of
the healthcare team to prevent further harm and enhance therapeutic outcomes by providing
astute assessment and management of complications in patients undergoing induced
hypothermia. The desired outcome of this review is to promote integration of research in the
development of evidence-based protocols for induced hypothermia.

Key Words
Induced hypothermia, ischemia, cardiac arrest, traumatic head injury, adverse effects,
metabolism, metabolic rate, complications, and nursing interventions.
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CHAPTER ONE: Introduction
Background
Cardiac arrest, stroke, and head trauma may lead to compromised cerebral perfusion.
Ischemia in the brain triggers an inflammatory response resulting in cerebral damage.
Compensatory mechanisms rapidly exhaust oxygen reserves, and the brain transitions into a state
of anaerobic metabolism for survival (McKean, 2009). Anaerobic metabolism in response to
ischemia precipitates a state of acidosis, which leads to disintegration of cell membranes and cell
death (Finkelstein & Alam, 2010). Initiating a state of hypothermia in ischemic situations is
believed to decrease the metabolic rate and lower cerebral oxygen demands. Animal studies have
shown that a reduction in body temperature decreases the activity of sodium-potassium
adenosine triphosphate synthase (ATPase) resulting in a conservation of adenosine triphosphate
(ATP) (Finkelstein & Alam, 2010).
In the 1950s, hypothermia was first studied as an approach to preventing neurological
dysfunction during cardiac surgery. Animal studies were followed by human trials which largely
replicated the evidence that induced hypothermia (IH) lowers intracranial pressure, contributes to
improved neurological outcomes, and reduces mortality in populations at risk for neurological
dysfunction from cerebral ischemia (Oddo, Schaller, Feihl, Ribordy, & Liaudet, 2006; Zeitzer,
2005; Zhi, Zhang, & Lin, 2003). In 2002, two landmark studies presented supporting evidence
that IH was the intervention of choice to preserve neurologic function for patients in post-cardiac
arrest (Safer & Kochanek, 2002; The Hypothermia after Cardiac Arrest Study Group, 2002). In
addition to cardiac arrest, research has expanded to explore application of IH in cases of
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traumatic brain injury, stroke, spinal cord injury, bacterial meningitis, and neonatal hypoxicischemic encephalopathy (Finkelstein & Alam, 2010; Bernard & Buist, 2002).
Problem
Research study results point favorably toward ongoing use of IH. This treatment
modality, however, encompasses a variety of complex variables that have the potential to
adversely affect patient outcomes. The preemptive problem in guiding the care of these patients
is the lack of evidence based protocols. Potential for rapid changes in patient condition and
serious adverse effects require close monitoring by the nurse and the foreknowledge to anticipate
needs and provide appropriate interventions.
Adverse effects of IH include shivering, which increases metabolic demands and oxygen
consumption, increased risk for infection, and decreased platelet count and function (McKean,
2009; Finkelstein & Alam, 2010). Electrolyte imbalances, specifically hypokalemia, can develop
rapidly during hypothermia and adversely affect heart rate and rhythm among other
physiological functions (Finkelstein & Alam, 2010). Cardiovascular alterations, including
bradycardia, hypotension, and dysrhythmias can further complicate the patient’s status. Risks
during rewarming include rebound hyperthermia and increased intracranial pressure (ICP)
(McKean, 2009).
The complications associated with IH emphasize the importance of skilled nursing care
and management for patients undergoing induced hypothermia. Development of evidence based
protocols would promote patient safety by increasing awareness of complications and enhancing
anticipation and management of patient needs.
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Purpose
The purpose of this thesis was to provide a review of research findings on the
physiological complications of IH and implications for nursing practice. Use of IH is increasing,
yet patient care protocols are lacking. By increasing nursing awareness, complications can be
managed in a way that promotes optimal patient functioning following treatment. This literature
review is designed to integrate research findings that may promote development of evidence
based patient care protocols.
Method
A synthesis of current research on IH was conducted for this thesis. The databases
selected for the literature review included CINAHL, Medline, and the Cochrane Database of
Systematic Reviews. Induced hypothermia in adult populations with witnessed cardiac arrest and
traumatic head injury were the target populations. However, other forms of neuronal insult were
explored as well. Search terms used were induced hypothermia, therapeutic hypothermia,
complications, effects, fluid and electrolyte imbalance, arrhythmias, dysrhythmias, and review.
Dates of research studies focused on studies published between the years 2000-2010 and
included peer-reviewed articles and those written in the English language. Studies conducted in
the United States and internationally were used in the literature review. Neonates receiving
treatment for encephalopathy and pediatric populations were excluded from this thesis to direct
focus toward complication management in adult populations.
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Pathophysiology
The control center for thermoregulation is the hypothalamus. Normal body temperature is
maintained within a narrow range of 36.6° + 0.38°C to promote optimal metabolic function.
Thermoreceptors located in the skin, hypothalamus, spinal cord, and abdominal organs provide
feedback to the hypothalamus on the status of core and peripheral body temperature. Body heat,
generated through metabolism and chemical thermogenesis, is distributed to all body tissues via
the circulatory system. Limiting or increasing blood flow via vasoconstriction or vasodilation
allows the body to regulate temperature, thereby maintaining a state of homeostasis (Polderman,
2004). When the hypothalamus senses a drop in temperature, peripheral vasoconstriction occurs
and blood is shunted to the core where heat can be retained. Cooler body temperatures result in
increased muscle tone in the form of shivering and contribute to a rise in temperature by
increasing metabolic rate (Huether & McCance, 2008). In contrast, vasodilation occurs when
body temperature rises, thereby increasing the volume of blood that reaches peripheral
circulation for cooling (Polderman, 2004). Hyperthermia accelerates the rate of cell damage.
When body temperature reaches 41°C, nerve damage occurs resulting in convulsions and
eventual death (Huether & McCance, 2008).
Hypothermia decreases overall metabolic rate and specifically influences cerebral
metabolic rate (Polderman, 2004). Desirable effects of hypothermia when ischemia and
inflammation are present in the heart or brain are reduction in cellular oxygen demands and
slowed rate of cellular death. In fact, donor organs being preserved for transplantation are kept
on ice until transplant for this very reason. The neuroprotective quality of hypothermia has
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created interest in inducing hypothermia as a therapeutic option for protecting the heart and brain
when ischemia is present (Polderman, 2004; Zhi, Zhang, & Lin, 2003).
History of Induced Hypothermia
The first documented use of IH took place in 1937 on a cancer patient in an attempt to
decrease the rate of metastatic cellular division. Results in this patient showed no change in the
rate of cellular division with IH. Over the following decade IH continued to be used as a
treatment for cancer. Patients reportedly tolerated the treatment well, but the therapy failed to
slow the rate of cancer progression (Bernard & Buist, 2003). In the early 1940s, IH was first used
for the purpose of improving neurological function in patients with head injury. Inducing a mild
state of hypothermia during cardiac surgery was first introduced in 1950 and remains the
recommended standard of practice for many cardiac surgical procedures because of its
neuroprotective quality (Bernard & Buist, 2003). Animal trials began in the 1950s to examine the
benefits of hypothermia as a therapeutic treatment and continued into the 1990s. Beginning in
the 1990s, IH was specifically examined for its role in increasing central venous oxygen levels
and decreasing arterial lactate concentrations in cases of head injury and witnessed cardiac arrest
(McKean, 2009). Clinical trials validated the laboratory findings that IH reduced cerebral
metabolism and improved neurological outcomes. The release of two landmark studies in 2002
presented IH as the best practice to preserve neurological function in patients following cardiac
arrest (Safer & Kochanek, 2002; The Hypothermia after Cardiac Arrest Study Group, 2002). The
use of IH to counteract secondary brain injury as a result of trauma and stroke are currently being
implemented in some of the larger hospitals in the United States. Induction of IH is also now
being considered for use by paramedics prior to hospital admission in patients with witnessed
5

cardiac arrest. The benefits of pre-hospital hypothermia are currently under investigation. Initial
results appear promising, but research in this field is limited. In spite of research in support of
this therapy, guidelines for implementing IH are lacking.
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CHAPTER TWO: Research Findings
Indications for Treatment
Hypothermia continues to grow in use in contemporary medicine, encompassing a
widening spectrum of medical conditions where ischemia is the common denominator.
Considered a recommended therapy following witnessed cardiac arrest, IH is now being
implemented in some cases of stroke, spinal cord injury, traumatic brain injury, hepatic
encephalopathy, and bacterial meningitis with initial research initiatives showing favorable
outcomes (Finkelstein & Alam, 2010; Bernard & Buist, 2002).
Cardiac Arrest and Anoxic Brain Injury
Patients who are unresponsive after witnessed cardiac arrest are recommended for IH.
Patients admitted to the hospital in cardiac arrest often sustain severe neurologic injury due to the
loss of cerebral perfusion (Bernard & Buist, 2003). The American Heart Association (AHA)
recommends IH for patients of cardiac arrest whose underlying rhythm is ventricular fibrillation,
although IH may also be beneficial in cases of non-ventricular fibrillatory arrest (McKean,
2009). Identification of appropriate cases for IH includes consideration of initiation and duration
of resuscitation efforts.
In one study, acceptable criteria for IH included cardiac arrest patients on whom
resuscitation efforts were initiated within 15 minutes of arrest (Bernard & Buist, 2003). Oddo et
al. (2006) conducted a retrospective study on the impact of IH on 109 patients who were
survivors of out-of-hospital cardiac arrest. Heart rhythms for these patients were ventricular
fibrillation, asystole, or pulseless electrical activity (PEA). Patients were cooled to 33°C using
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external cooling methods. Hypothermia was maintained for 24 hours followed by passive
rewarming. During hypothermia, patients were mechanically ventilated and received sedation,
analgesia, and paralysis. Study results compared patient outcomes between those treated with IH
and patients treated with standard resuscitation methods. Standard resuscitation methods
included maintaining mean arterial blood pressure (MAP) between 75-80 mm Hg and
maintaining PaCO2 between 36-40 mm Hg. Outcomes were measured using the GlasgowPittsburg Cerebral Performance Categories (CPC), which measures patient functionality. Of the
patients in the experimental group whose presenting rhythm was ventricular fibrillation (VF),
55.8% had good outcomes (CPC 1-2) in contrast to 25.6% from the control group (p=0.004).
Poor outcomes (CPC 3-5) were associated with patients from both groups whose presenting
rhythm was either PEA or asystole. Results showed direct correlation between IH and improved
functionality following cardiac arrest (Oddo, Schaller, Feihl, Ribordy, & Liaudet, 2006).
Traumatic Head Injury
IH was considered an acceptable treatment for traumatic head injury in the 1950s but was
abandoned with the development of intensive care units. Treatment for traumatic head injury is
directed at minimizing secondary cerebral injury by promoting cerebral oxygenation. IH is now
being reconsidered and reintroduced by some hospitals as a treatment modality to manage
complications of traumatic head injury (Bernard & Buist, 2003). The premise for IH in traumatic
head injury is the decrease in oxygen demands and reduction of ICP afforded by this therapy.
Existing research shows IH to be non-therapeutic in traumatic head injury and is largely
controversial, although further investigation is warranted (Bernard & Buist, 2003).

8

A randomized study conducted by Clifton et al. (2001) examined the use of IH on 392
patients admitted to the hospital with severe head injury. Patients in the hypothermia group
(n=199) were cooled to 33°C for 48 hours. Although patients in the hypothermia group (n=199)
experienced a reduction in intracranial pressure greater than their counterparts in the control
group (n=193), there was no difference in functional outcomes between the two groups 6 months
following treatment (Clifton et al., 2001). Limitations in methodology may have impacted
patient outcomes in this study. Patients with hypoxia or hypotension following initial
resuscitation efforts were excluded from this study and may have benefited from reduced oxygen
demands and consumption afforded by IH. Furthermore, the mean time for initiating IH was 8
hours following traumatic head injury. Lastly, rewarming was initiated after 48 hours of
treatment regardless of intracranial pressure measurements, allowing patients with intracranial
hypertension who may have benefitted from additional IH to be rewarmed (Clifton et al., 2004).
Stroke
Although first line treatment for ischemic stroke is aimed at early thrombolytic therapy,
treatment for stroke patients is largely supportive in nature. When a stroke occurs, a core of
irreversibly dead tissue exists at the site of infarction. Surrounding the infarction is a region of
hypoperfused tissue known as the ischemic penumbra. The focus of stroke management is on
restoring perfusion to the area of ischemia, thereby minimizing the extent of neurological
damage (Bernard & Buist, 2003). IH is an intervention that may be beneficial in this patient
population. Increased body temperature is an adverse effect of stroke and is associated with
adverse outcomes and increased mortality rates. Preclinical trials have shown improved
outcomes in the use of IH in patients with ischemic stroke (Bernard & Buist, 2003).
9

A prospective study of 390 stroke patients was conducted to see if laboratory findings
that cerebral ischemia improved with hypothermia could be validated in humans following
ischemic stroke. The study was conducted on patients who were admitted to the hospital within 6
hours of stroke symptom onset and examined the correlation between body temperature on
admission and the infarct size, mortality rates, and survivor outcomes. Patients presenting with
hyperthermia had increased rates of mortality and poorer outcomes at discharge. Functional
outcomes were measured using the Scandinavian Stroke Scale (SSS). Findings affirmed that
body temperature was directly related to stroke severity (p<0.009), infarct size (p<0.0001),
mortality (p<0.02), and survivor outcomes (p<0.002) (Reith et al., 1996). Although this study
was conducted prior to clinical application of IH in stroke patients, it validated the
neuroprotective nature of IH in this specific population.
A preliminary clinical trial conducted on 50 patients with ischemic stroke used IH to
lower ICP and minimize secondary infarction. Hypothermia-induced complications were as
follows: 70% experienced thrombocytopenia, 62% had bradycardia, and 48% developed
pneumonia. Complications during rewarming occurred in 30% of those studied. In spite of these
complications, outcomes found IH to effectively control ICP and reduce functional and
neurological deficits. Patient outcomes were evaluated at 4 weeks and 3 months using the
National Institutes of Health Stroke Scale (average score of 29 at 4 weeks) and the Rankin Scale
(average score of 2.9 at 3 months) (Schwab et al., 2001).
Hepatic Encephalopathy
IH for treatment of hepatic encephalopathy focuses on reducing increased ICP associated
with acute liver failure. Animal studies have shown that IH reduced the levels of ammonia10

induced cerebral edema (Bernard & Buist, 2003). A study conducted by Rose et al. (2000)
examined the impact of hypothermia on rats with ammonia-related cerebral edema secondary to
liver failure. Cooled to 35°C, the experimental group showed decreased ammonia levels in
cerebrospinal fluid and lower levels of extracellular glutamate than the control group, providing
positive support for the theory that IH is effective in reducing ammonia-induced cerebral edema
(Rose et al., 2000).
Two research studies conducted by Jalan et al. (1999; 2001) evaluated the effects of IH in
patients with hepatic encephalopathy. In the first study, patients were cooled to 32°-33°C for a
mean time of 32 hours. In the second, patients were cooled to the same temperature range 24
hours prior to surgery for liver transplantation and maintained between 32-33°C until the
postoperative period. IH was effective in managing increased ICP for patients in acute liver
failure awaiting liver transplants who did not respond to standard treatment with mannitol and
ultrafiltration. Positive outcomes were a reduction in ICP by an average of 54 mm Hg, decreased
arterial ammonia levels, and decreased cerebral uptake of ammonia. Neither study documented
any long-term adverse effects of hypothermia (Jalan, Damink, Deutz, Lee, & Hayes, 1999; Jalan
& Damink, 2001).
Bacterial Meningitis
IH has the potential to lower ICP, blunt any hyperemic response in cerebral blood flow,
and decrease leukocyte count in cerebral spinal fluid (CSF) (Bernard & Buist, 2003). Animal
studies have been conducted to explore the possibility of using IH in the treatment of bacterial
meningitis. Pneumococcal meningitis was introduced to rats that were then treated with IH to
assess the impact of IH on cerebral blood flow and ICP. The study found that IH lowered
11

cerebral blood flow and ICP in addition to decreasing tumor necrosis factor and cerebrospinal
fluid leukocyte count (Angstwurm et al., 2000). Clinical trials have not been started, but
application of IH in this patient population may be considered (Bernard & Buist, 2003).
Spinal Cord Injury
A limited number of animal studies analyzed the possibility of using IH to improve
outcomes with spinal cord injury. While direct damage to the spinal cord is likely irreversible, IH
may be useful in preventing secondary injury related to altered perfusion, ischemia, and
inflammation (Finkelstein & Alam, 2010). Animal trials in the 1960s and 1970s looked for
correlations between IH and improved outcomes with spinal cord injury. Results were
inconclusive with only limited studies showing benefit of IH therapy. Animal studies on the use
of IH for spinal cord injury resumed a decade ago as IH was becoming more widely used to treat
cerebral inflammation and ischemia. Study results showed that IH provided a measure of
cerebral protection, but improvement of functional outcomes was lacking (Inamasu, Nakamura,
& Ichikizaki, 2003). Additional preclinical studies need to be completed before therapeutic
benefits can be determined (Finkelstein & Alam, 2010).
Exclusion Criteria
In a literature review, McKean (2009) concluded that IH is not recommended for patients
with life-threatening arrhythmias or those who are pregnant due to the lack of available research
among these patient populations (McKean, 2009). Primary coagulopathy was also a
contraindication for this therapy because of the potential for IH to further impede coagulation
(McKean, 2009). Immunosuppression and sepsis were also considered contraindications for IH
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due to increased risk for infection. IH was not recommended for persons with cardiac arrest
secondary to respiratory compromise, or for patients with a systolic blood pressure of less than
90 mm Hg (McKean, 2009). Hypotension and decreased cardiac output have the potential to
adversely affect cerebral perfusion pressure (CPP), which may be difficult to manage in patients
presenting with hypotension (Huether & McCance, 2008). Similar exclusion criteria were listed
in literature presented by Hoag Memorial Hospital Presbyterian. Exclusion criteria were
subdivided into two groups: absolute and relative. Absolute exclusion criteria were listed as
pregnancy, coma resulting from drug overdose, status epilepticus, and terminal illness. Relative
exclusion criteria included preexisting coagulopathy, thrombocytopenia, preexisting
hypotension, and bradycardia. Hoag Memorial established its exclusion criteria based on a
review of functional outcomes of patients treated with hypothermia following cardiac arrest
(Pyle, Pierson, Lepman, & Hewett, 2007).
Methods for Inducing Hypothermia
Noninvasive Cooling Measures
Cooling by conduction utilizes a cooling blanket that circulates chilled water. Cooling by
convection uses fans to circulate cool air over the patient. These cooling methods generally
produce slower reduction in core body temperature than invasive techniques. One study showed
the use of cooling blankets to reduce body temperature by 1°C in a mean time of 178 minutes.
Fans reduced core body temperature by a single degree in 142 minutes (Bernard & Buist, 2003).
Additional methods of noninvasive cooling are alcohol baths, ice packs placed on the torso, groin
and axillae, and immersion in ice water. Ice packs cool body temperature at an average rate of

13

0.9°C per hour. Immersion in ice water is effective in lowering body temperature but is difficult
to implement in any hospital or pre-hospital setting (Bernard & Buist, 2003).
The above noninvasive methods of inducing hypothermia tend to be labor intensive for
healthcare workers implementing the treatment and require close monitoring of the patient’s
temperature which can be erratic and unpredictable. Nursing judgment plays a significant role in
the care of patients receiving noninvasive cooling since treatment requires continuous adjustment
based on the patient’s response to the intervention. Noninvasive cooling methods are associated
with greater risk for accidental overcooling and excessively rapid rewarming. An additional
concern is the prolonged time it may take to achieve target body temperature by surface cooling
methods (McKean, 2009).
An exception to the aforementioned noninvasive cooling methods are external cooling
devices such as the Arctic Sun. Advances in technology have led to the development of
noninvasive cooling methods that regulate the rate at which body temperature is lowered and
raised and provide continuous feedback on core body temperature. Arctic Sun uses adherent gel
pads attached to the patient’s torso and lower extremities to circulate chilled fluids. Arctic Sun
contains a temperature feedback-control mechanism that improves thermoregulation by allowing
temperature to be raised or lowered on demand. An additional benefit is the ability to reach
target core body temperature more rapidly than with other external cooling devices (Heard et al.,
2009).
A randomized control trial completed in 2009 compared the use of Arctic Sun to ice and
cooling blankets for inducing hypothermia following cardiac arrest (Heard et al., 2009). The
percentage of participants in the Arctic Sun group who reached target core body temperature
14

within four hours of induction was 71% in contrast with 50% for the control group (p = 0.12).
Neurological function and survival rates were slightly higher in the Arctic Sun group at 46%
compared with 38% in the control group (p = 0.6) (Heard et al., 2009). While cooling blankets
and ice do effectively cool patients, improved technology, such as Arctic Sun, provide greater
efficiency in cooling with the added benefit of precise temperature control (Heard et al., 2009).
Invasive Cooling Measures
Rapid infusion of chilled IV fluids and intravascular cooling catheters are invasive
methods of inducing hypothermia. Intravascular catheters inserted via a central vein into the vena
cava circulate chilled fluid from an external refrigerated pump through a closed catheter.
Preliminary research shows intravascular catheters to be an effective technique for cooling core
body temperature. Risks associated with this cooling method include bleeding, deep vein
thrombosis, vascular puncture, and infection, and must be weighed against therapeutic benefits
(Bernard & Buist, 2003).
A pilot study by De Georgia et al. (2004) assessed the use of intravascular cooling
catheters in patients following ischemic stroke. Eighteen participants were included in the study.
Intravascular cooling was chosen because it facilitated quick access and rapid cooling. Target
core body temperature of 33°C was attained within 2 hours of catheter placement for 14 of the 18
participants, in contrast with the standard 4-6 hours required by other cooling methods.
Hypothermia was successfully maintained for 24 hours. Occurrence of complications was
comparable to those in the control group and patients remained hemodynamically stable for the
duration of treatment. Participants who experienced complications had similar variables
including advanced age and greater stroke severity. One exception was a patient who
15

experienced retroperitoneal hemorrhage. This patient was a poor candidate for intravascular
cooling due to administration of antithrombolytics and anticoagulants prior to catheter insertion.
Results of the study showed that hypothermia reduced the size of infarct growth, but functional
outcomes were the same in both the experimental and control groups (De Georgia et al., 2004).
Regional Cooling Measures
Partial body hypothermia uses a regional cooling device such as a cooling helmet to
provide localized brain cooling. Theoretically, providing therapeutic benefits of cooling without
subjecting the body to the systemic effects of whole body hypothermia could optimize treatment
outcomes by minimizing the risk for complications. Research, however, is conflicting and use of
cooling helmets needs to be further researched. Some studies have shown that cooling helmets
are useful in providing regional hypothermia; however, after 24 hours of use, they begin to
reduce core body temperature (Bernard & Buist, 2003; Finkelstein & Alam, 2010). An article by
Kuffler (2010) supported the use of head cooling in combination with mild total body
hypothermia to minimize the complications associated with systemic, moderate IH.
Potential Adverse Effects of Induced Hypothermia
Shivering
Core body temperature is tightly regulated by the hypothalamus between 36.5°-37.5°C.
Changes outside normothermic range initiate thermoregulatory responses within the
hypothalamus. Hypothermia triggers the body’s compensatory mechanisms to increase heat
production. One mechanism is increased muscle tone in the form of shivering, which causes the
body to generate heat two to five times the normal rate (Mahmood & Zweifler, 2007). In the
16

induced hypothermic state, shivering potentiates an increase in metabolic demands and cellular
oxygen consumption. This is most likely to occur during the induction and rewarming phases of
IH (McKean, 2009). Increased metabolic rate and oxygen consumption are counterproductive
during IH, and must be overcome to increase the efficacy of treatment (Mahmood & Zweifler,
2007).
Pharmacologic agents are used to suppress shivering and include paralytics and
nonvolatile anesthetics. Propofol (Diprivan) is a benzodiazepine that impairs vasoconstriction
and is useful as a sedative and anxiolytic for mechanically ventilated patients (Sole, Klein, &
Moseley, 2009). Propofol is the medication of choice to prevent shivering in IH patients
(Mahmood & Zweifler, 2007). Meperidine (Demerol) is an opioid used as an anesthesia adjunct
and has also been shown to suppress shivering during IH (Deglin & Vallerand, 2009; Mahmood
& Zweifler, 2007). Other medications used for patient sedation and comfort are fentanyl
(Sublimaze) and midazolam (Versed) (Deglin & Vallerand, 2009). Neuromuscular blocking
agents provide therapeutic paralysis and include atracurium (Tracrium) and succinylcholine.
Prior to administering paralytics and sedatives, the patient must be intubated to maintain airway
patency and placed on a ventilator until the use of sedation is suspended (Sole, Klein, &
Moseley, 2009). Current research validates the suppression of shivering from the onset of IH
through the duration of treatment until the body is rewarmed and returned to a normothermic
state (McKean, 2009).
Nursing assessment should include monitoring for signs of shivering such as increased
respiratory rate and muscle tensing of chest or facial muscles. Other signs of shivering may
include a reduction in venous oxygen saturation or a static tracing on the electrocardiogram
17

(ECG). Although it may be difficult to obtain due to peripheral vasoconstriction, a train of 4
should be established on the patient and monitored throughout the sedation period (McKean,
2009). Nursing assessment may be enhanced by the use of bispectral index monitoring to provide
optimal sedation and reduce the risk of oversedation or excessive paralysis.
Cardiovascular Changes
The body’s normal response to hypothermia is decreased heart rate, increased cardiac
output, and peripheral vasoconstriction in an attempt to shunt blood to the vital organs and body
core in an effort to conserve heat. Cardiovascular changes occur in two phases as body
temperature lowers to a hypothermic state. During the induction phase heart rate is increased,
thereby increasing cardiac output. Blood pressure also rises due to increased systemic vascular
resistance. This compensatory mechanism allows greater volumes of warm blood to be circulated
throughout the body to warm the tissues. As hypothermia persists and core body temperature
lowers, bradycardia develops, afterload decreases, and cardiac oxygen demands are reduced
(Polderman, 2004). Hypotension and dysrhythmias are two adverse cardiovascular effects seen
during this phase of IH. The use of sedatives or paralytic agents compounds the body’s natural
response causing bradycardia and increased systemic vascular resistance (Bernard & Buist,
2003).
To compensate for increased arterial pressure, the kidneys respond with diuresis in an
effort to lower blood pressure. Within hours, the body may lose large amounts of water (Guyton,
1991). Ensuing hypotension and decreased cardiac output have the potential to adversely affect
CPP. If pressure in the vasculature of the brain is inadequate, oxygenation of cerebral cells will
be insufficient (Huether & McCance, 2008). An injured brain is highly sensitive to changes in
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blood volume and pressure and cannot survive long without adequate oxygenation (Finkelstein &
Alam, 2010). Inadequate CPP leads to cerebral ischemia within three minutes and cerebral
infarction in five minutes (Sole, Klein, & Moseley, 2009).
Hemodynamic monitoring is critical in these patients to assess fluid volume status and
maintain adequate cerebral perfusion. Invasive hemodynamic monitoring devices include arterial
lines, central venous catheters, and pulmonary artery catheters. Complications associated with
these devices are infection, bleeding, pneumothorax or hemothorax, thrombosis, cardiac
dysrhythmias, and pericardial tamponade. Proper management of arterial catheters includes
zeroing the transducer at the start of every shift, when the patient is repositioned or moved, and if
there is a significant change in patient status (Sole, Klein, & Moseley, 2009).
Fluid replacement is important to ensure adequate fluid volume and cerebral perfusion.
The fluid of choice during hypothermia is 0.9% normal saline. Normal saline helps maintain
optimal CPP and mean arterial pressure (MAP) (Sole, Klein, & Moseley, 2009).
Monitoring vital signs provides the nurse with critical information regarding the patient’s
response to hypothermia. Continuous blood pressure monitoring is essential in IH patients.
Arterial catheters provide accurate measurement of systemic blood pressure and are the modality
of choice for patients undergoing IH (Sole, Klein, & Moseley, 2009). Cerebral oxygenation
monitoring is another valuable tool that allows the healthcare team to assess cerebral perfusion
by the placement of a jugular venous bulb via the internal jugular vein. The monitor measures
the level of oxygen saturation of the blood as it leaves the brain (Sole, Klein, & Moseley, 2009).
Research on appropriate CPP levels is conflicting. During induced hypothermia one study
suggested maintaining a CPP of 60 mm Hg (Finkelstein & Alam, 2010). According to Huether
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and McCance (2008), a CPP of more than 70 mm Hg is recommended. Normal adult CPP is
between 60-100 mm Hg. Decreased MAP or increased ICP causes CPP to be lowered. During
hypothermia, a lower CPP may be acceptable because of decreased metabolic rate (Sole, Klein,
& Moseley, 2009).
Hypothermic patients are also at risk for developing dysrhythmias. These can occur in
response to decreased coronary perfusion and increased myocardial irritability. Without oxygen,
the myocardium becomes fatigued and escape mechanisms replace normal conduction pathways.
Although the heart can withstand episodes of ischemia for longer periods than the brain before
infarct occurs, adequate perfusion is essential for proper function (Sole, Klein, & Moseley,
2009).
Hypokalemia is a common occurrence during IH due to cellular shifts of fluids and
electrolytes. Potassium is essential for cellular metabolism and plays an essential role in
neuromuscular function. Hypokalemia impacts resting membrane potential and specifically
impacts the electrical conductivity of the myocardium by reducing cellular excitability. ECG
changes associated with hypokalemia include flattened T waves, emergence of U waves, and
peaked P waves (Lewis, Heitkemper, Dirksen, O’Brien, & Bucher, 2007). Dysrhythmias may
develop at any point during IH, but are most likely to occur during the induction and rewarming
phases (McKean, 2009).
Research findings showed the risk for dysrhythmias increased when body temperature
fell below 30°C (McKean, 2009; Polderman, 2004). The most common ECG changes seen in
patients with temperatures below 32°C were first-degree heart block and prolonged QT segment
(Finkelstein & Alam, 2010). Tachydysrhythmias, most commonly atrial fibrillation, were
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associated with temperatures between 30°-33°C. In deep, hypothermic states (less than 28°C),
ventricular dysrhythmias were problematic (Finkelstein & Alam, 2010).
Nurses managing the care of IH patients should be aware of the risk for hypothermiainduced dysrhythmias and monitor for changes in heart rate and rhythm. Early recognition of
ECG changes followed by early intervention reduces strain on the heart and helps reduce risk for
more serious dysrhythmias (Sole, Klein, & Moseley, 2009). Treatment of dysrhythmias involves
standard medical interventions, although dysrhythmias may be more difficult to treat due to the
impact cold temperatures have on the myocardium. Awareness of alterations in drug metabolism
is an important factor in treating dysrhythmias (Finkelstein & Alam, 2010; McKean, 2009).
Hypothermic patients may require lower or less frequent doses of antiarrhythmic medications
due to slower drug metabolism (McKean, 2009).
Coagulopathy
Hypothermia depletes clotting factors and clotting proteins and activates both intrinsic
and extrinsic pathways causing the release of procoagulants. Consumption of clotting factors in
the microcirculation increases systemic risk for bleeding. Uncontrolled clot formation throughout
the microvasculature also increases the risk of organ ischemia and damage (Sole, Klein, &
Moseley, 2009). Methods for assessing coagulation include platelet count, fibrinogen level,
fibrin degradation products (FDPs), international normalized ratio (INR), prothrombin time (PT),
and activated partial thromboplastin time (aPTT) (Sole, Klein, & Moseley, 2009).
The studies under review used PT and aPTT as the methods of choice for assessing risk
for bleeding in hypothermic patients. Preclinical trials showed varying impact of IH on bleeding
tendencies. A meta-analysis revealed only slight increase in PT between the hypothermic and
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normothermic groups by 0.02 seconds (p=0.7) (Harris, Colford, Good, & Matz, 2002). One of
four research studies conducted by a traumatic brain injury group showed an increased PT during
IH (Finkelstein & Alam, 2010). According to Polderman (2004), IH was not associated with
increased intracranial bleeding in clinical trials for patients with stroke, subarachnoid
hemorrhage, or traumatic brain injury. Two human trials showed no increased risk for bleeding
during mild to moderate hypothermia (28°-36°C) (McKean, 2009, Clifton et al., 2001). The risk
for bleeding increased when body temperature was decreased to below 28°C (Finkelstein &
Alam, 2010).
Assessment for signs and symptoms of coagulopathy should include monitoring for
changes such as cyanosis of the fingers, toes, and nose, and delayed capillary refill. Oliguria, a
possible sign of coagulopathy, may be difficult to monitor in patients who are vasoconstricted
due to hypothermia. Patients should also be closely monitored for signs of bleeding such as
gingival bleeding, petechiae, echymosis, oozing at venipuncture sites, and stool positive for
occult blood (Sole, Klein, & Moseley, 2009).
Infection
Hypothermia inhibits proinflammatory responses by decreasing the number of circulating
leukocytes, suppressing phagocytosis, and decreasing the synthesis of proinflammatory
cytokines (Polderman, 2004). Hypothermia places patients at increased risk for developing
infection and sepsis. Meningitis, pneumonia, and wound infections or prolonged wound healing
are the most common infections associated with induced hypothermia (Finkelstein & Alam,
2010). Immunosuppression, in addition to intubation and mechanical ventilation, place ventilated
patients at greater risk for developing ventilator-associated pneumonia (VAP) (Sole, Klein, &
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Moseley, 2009). Hypothermia impairs ciliary function of the upper airways, thus inhibiting one
of the body’s natural defense mechanisms (McKean, 2009). Wound infections associated with IH
are attributed to diminished leukocyte function and hypoperfusion resulting from hypothermiainduced vasoconstriction (Polderman, 2004).
Infection, specifically pneumonia, occurred in higher numbers when the hypothermic
period lasted greater than 48 hours (Polderman, 2004). Incidence of hypothermia-related
pneumonia was one of the documented complications found in 11 trials (n=559). Patients in
hypothermic groups had a moderately higher risk for acquiring pneumonia than the control
groups, but in these studies the increase was not shown to be significant (confidence interval
0.95-1.91) (Sydenham, Roberts, & Alderson, 2009). Infections that did occur responded well to
treatment once the patients were rewarmed (Finkelstein & Alam, 2010).
Strategies to reduce the risk for infection during IH include maintaining the head of the
patient’s bed between 30°- 45°C if not contraindicated by patient condition. Raising the head of
the bed helps reduce risk for aspiration and prevent gastric reflux. Suctioning of mechanically
ventilated patients and providing oral hygiene are important aspects of nursing care to reduce the
risk for pneumonia (Sole, Klein, & Moseley, 2009). Laboratory indicators for infection are white
blood cell (WBC) count with differential and blood cultures and should be routinely monitored
throughout the hypothermic period (Greer, 2005). Skin care and frequent turning help maintain
skin integrity (McKean, 2009). Additional protective measures include antibiotic prophylaxis
and decontamination of the gastrointestinal tract (Polderman, 2004). IH masks elevation in body
temperature associated with infection, placing greater responsibility on nurses to use proactive
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measures to prevent infection and astute assessment to detect the earliest signs of infection
(McKean, 2009).
Fluid and Electrolyte Imbalances
Induction of hypothermia causes a significant shift of electrolytes from the extracellular
fluid (ECF) to the intracellular fluid (ICF) causing serum levels of potassium to drop (Huether &
McCance, 2008). In addition to the intracellular shift, decreased renal reabsorption of solutes
leads to increased secretion of electrolytes (Bernard & Buist, 2003). A reduction in calcium,
potassium, sodium, magnesium, and phosphate are all possible findings due to shifts in
electrolytes and urinary diuresis (Finkelstein & Alam, 2010). One of the most concerning
changes is a shift of potassium into the cells resulting in extracellular hypokalemia. Potassium
plays a vital role in electrical impulse conductivity, and has specific impact on the myocardium.
Cardiac dysrhythmias, including bradycardia and ECG changes such as a depressed ST segment,
flattened T wave, and prolonged QT segment, are findings associated with hypokalemia (Sole,
Klein, & Moseley, 2009). Hypomagnesemia is a finding associated with poor patient outcomes
when experienced in conjunction with neurological injury and may be seen with hypothermia
(Finkelstein & Alam, 2010).
Electrolyte monitoring is essential in patients undergoing IH. ECG readings should be
closely monitored for changes consistent with hypokalemia. Replacement of potassium levels
requires diligent and frequent monitoring as levels can drop dramatically and rapidly throughout
the hypothermic phase. There are two options for replacing potassium during hypothermia. The
first is to maintain normal serum potassium levels. The second is to replace measured losses of
potassium. In one research study, patients whose potassium was maintained at a normal serum
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level during hypothermia, developed hyperkalemia during the rewarming phase and more
frequently experienced dysrhythmias. Patients whose potassium was replaced according to
measured losses stayed within normal levels during rewarming and did not experience
dysrhythmias (Koht, Cane, & Cerullo, 1983). While it is commonly thought that electrolyte
levels should be maintained in the high range of normal, it may be wise to replace only measured
losses in the case of potassium (Finkelstein & Alam, 2010).
Magnesium plays an important role in neuromuscular excitability. Effects of
hypomagnesemia include hyperreflexia, muscle cramps, convulsions, tachycardia, and
hypotension (Huether & McCance, 2008). Magnesium replacement during IH may benefit the
patient by preventing vasospasm and aid in regulating the body’s transition during reperfusion.
According to Finkelstein and Alam (2010), hypomagnesemia during induced hypothermia was
associated with increased mortality and poor outcomes in patients with neurological injury. In
cases of traumatic brain injury, supplementing magnesium resulted in improved patient outcomes
(Finkelstein & Alam, 2010).
In addition to replacing electrolytes, slow infusions of hypertonic saline may be
administered if electrolyte levels are critically low and electrolyte levels are not improving
sufficiently with replacement therapy (Sole, Klein, & Moseley, 2009).
Adverse Metabolic Effects
During periods of hypothermia, the body functions in a hypometabolic state. Metabolic
rate decreases 5%-7% for each degree Celsius that body temperature is lowered (Polderman,
2004). Decreased metabolism impacts cellular uptake of insulin by increasing insulin resistance
and decreasing pancreatic secretion of insulin. Both of these factors place the body at risk for
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developing hyperglycemia (Finkelstein & Alam, 2010). Hyperglycemia increases susceptibility
to infection in vulnerable patients whose immune function is suppressed (Polderman, 2004).
There are no clear guidelines for the management of hyperglycemia during IH. Two
studies of patients with traumatic brain injury linked tight glucose control to improved patient
outcomes. Higher amounts of insulin were required during the induction phase of hypothermia to
maintain blood glucose within therapeutic range (Polderman, 2004). A clinical trial and metaanalysis, however, showed that tight glucose control involving frequent insulin administration
appeared to adversely impact patients and possibly contributed to increased mortality
(Finkelstein & Alam, 2010). A concern with aggressive administration of insulin during the
hypothermic phase is rebound hypoglycemia during rewarming (Polderman & Ingeborg, 2009).
A further consideration for glycemic control is the impact of hyperglycemia on blood viscosity.
Hyperglycemia increases blood viscosity, which decreases perfusion (Sole, Klein, & Mosely,
2009). Critical care nurses need to diligently assess blood glucose levels in these patients and
communicate with physicians to provide safe management of this potential adverse effect.
Research studies showed hyperglycemia to be the single greatest metabolic abnormality
associated with IH (Polderman, 2004; Finkelstein & Alam, 2010). Additional metabolic risks do
exist, however, including pancreatitis and impaired liver function that result in elevated liver
enzymes and amylase levels (Finkelstein & Alam, 2010). Hypothermia can lead to acidosis due
to increased levels of fatty acids, ketones, and lactate. This places the bowel at increased risk for
ulcer formation. Bowel ischemia due to hypoperfusion reduces gastrointestinal (GI) motility and
increases the risk of ileus and ulcer formation (Polderman, 2004). ICU protocols for GI antibiotic
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prophylaxis should be closely adhered to in IH patients (Finkelstein & Alam, 2010; Oddo et al.,
2006).
Reduced Drug Metabolism
The effects of hypothermia significantly impact pharmacokinetics and
pharmacodynamics. Enzymes necessary in the metabolism of most medications are highly
sensitive to changes in temperature. Drug clearance during hypothermia is decreased causing
plasma drug levels to be higher for prolonged periods of time, requiring lower doses of
medication to achieve the desired effects (Finkelstein & Alam, 2010; Polderman, 2004).
Consequently, standard dosing schedules may lead to plasma drug accumulation and toxicity.
Critical care nurses need to be cognizant of this fact and monitor for adverse effects of drug
toxicity such as respiratory depression and changes in heart rate or blood pressure.
Communication with the healthcare team, specifically physicians and pharmacists, is imperative
as drug doses and frequency of medication administration may need to be adjusted to prevent
toxicity (Lewis et al., 2007). Medications of specific concern for hypothermic patients are
opiates, sedatives, vasoactive drugs, nitrates, beta blockers, and neuromuscular blocking agents
(Polderman & Ingeborg, 2009).
Risks During Rewarming
Reperfusion injuries are exacerbated during the rewarming phase of IH. The brain’s shift
to anaerobic metabolism during initial loss of perfusion causes toxins to accumulate in the brain
(Zeitzer, 2005). Free radicals, cytokines, catecholamines, and nitric oxide are released when
reperfusion occurs (McKean, 2009). The presence of these chemicals furthers the injury when
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the body transitions from a hypothermic to normothermic state. Electrolyte imbalances,
specifically hyperkalemia, may occur during the rewarming phase as electrolytes shift from
intracellular spaces to the extracellular. Cellular uptake of insulin also increases as the body
returns to normothermia placing the patient at risk for hypoglycemia (Polderman & Ingeborg,
2009). Signs of medication toxicity should be closely assessed during the rewarming phase when
the body’s metabolism increases, thereby enhancing the uptake of pharmacotherapies
(Finkelstein & Alam, 2010). Other concerns include rebound hyperthermia and hypotension.
Rebound hyperthermia may increase cerebral edema and potentiates the risk for mitochondrial
damage and cell death, thereby reversing the therapeutic benefits of IH (McKean, 2009). The
rate at which body temperature is returned to a normothermic state must be monitored closely to
reduce the risk of recurring cerebral edema and increased intracranial pressure (McKean, 2009).
To prevent adverse effects of rewarming, studies suggest gradually increasing body
temperature by 0.5°-1.0°C per hour (McKean, 2009). Patient monitoring during the rewarming
phase should include assessment for electrolyte imbalances and dysrhythmias. Blood glucose
levels need to be monitored for hypoglycemia. Blood gasses should be assessed and oxygen
levels titrated to prevent oxidative stress from occurring as excessive oxygen is detrimental in
cases of post-ischemic neurological dysfunction. Vital signs should be continuously monitored
for changes in blood pressure, heart rate, and temperature. Shivering should continue to be
suppressed until normothermia is reestablished (McKean, 2009). Nurses should watch for ECG
changes such as bradycardia, first-degree heart block, and prolonged QT segment (Finkelstein &
Alam, 2010).
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Induced Hypothermia in the Prehospital Setting
Early implementation of IH has been shown to be effective in improving neurological
outcomes and minimizing secondary injury from ischemia. This finding has led to initiation of
this therapy by emergency medical service (EMS) personnel during prehospital transport
(Cabanas, Brice, Maio, Myers, & Hinchey, 2011). Numerous variables exist in the field, each
with the potential to impact effectiveness of IH delivery and management. Transport time may
range from less than ten minutes in a well-serviced city to more than an hour in rural settings.
EMS personnel possess a broad range of certification and experience. Some operate as
volunteers, others work full-time. Certification includes basic EMTs, paramedics, and in some
states, intermediate level EMTs. Equipment and protocols vary between providers and areas of
service. In order to analyze the benefits of IH, the risks of initiating this therapy in the
prehospital setting must be considered.
As outlined in this literature review, there are a number of possible adverse effects
associated with IH. Effectiveness of therapy is dependent on proper management of therapyinduced complications. In the field, paramedics do not have access to resources and equipment
necessary for monitoring these complications. A question to consider is could potential harm be
done by initiating this therapy in the field where there are limitations to what can be monitored?
One variable that comes into play is the duration of patient transport. During a short transport
time (<15-30 min.) it would be unlikely for body temperature to be lowered to the point where
complications would present a problem. On the other hand, a longer transport time (>30 min.)
may place the patient at risk for developing complications that could not be monitored until
hospital arrival. This raises a further question as to how EMS personnel should best prioritize
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their time. Performing lifesaving interventions, such as securing an airway, stopping
hemorrhage, immobilizing the C-spine or injured extremities, placing one or more IVs, obtaining
vital signs, and possibly ventilating a patient or performing CPR require full involvement by
paramedics and EMTs making it difficult to initiate other interventions such as IH.
The underlying question that needs to be determined is do the benefits of IH outweigh the
risks? Does initiation of IH in the field contribute to positive neurological outcomes, or would
the patient be better served by providing a speedy transport with preparatory communication to
emergency department staff to enable early intervention in the hospital where the patient can be
adequately monitored and assessed for complications? In order to answer these questions, further
research needs to be conducted on the use of IH in the prehospital setting (Cabanas, Brice, Maio,
Myers, & Hinchey, 2011).
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CHAPTER THREE: Conclusion
Implementation of Induced Hypothermia
Plan of Care
IH occurs in three phases: induction, hypothermic, and rewarming. Before the induction
phase is initiated, however, several factors should be determined. Appropriate patients should be
identified based on guiding criteria. IH may be beneficial for patients following cardiac arrest,
traumatic head injury, stroke, hepatic encephalopathy, bacterial meningitis, spinal cord injury,
and neonatal encephalopathy. IH is not recommended in patients with life-threatening
arrhythmias or those who are pregnant. Preexisting coagulopathy, immunosuppression, or sepsis
are also contraindications for IH. Use of IH with a systolic blood pressure of less than 90 mm Hg
or a history of recent surgery may place the patient at increased risk for complications and should
be avoided. (McKean, 2009).
A second consideration is unit staffing and resources. Physiological status may change
dramatically and rapidly during IH. A one-to-one nurse to patient ratio may be required to ensure
patient safety and should be considered when making patient assignments.
Better patient outcomes are associated with early initiation of IH. Studies concur that
induction of hypothermia should be implemented within 2-5 hours of anoxic brain injury or
cardiac arrest (Oddo et al., 2006). Studies currently suggest a target body temperature of 32°34°C for a period of 24-48 hours (McKean, 2009). If IH is rapidly initiated, a period of 12 hours
may be sufficient to produce therapeutic results. The rate at which body temperature is lowered
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varies by cooling method. The time it should take to reach target temperature is recommended
between 6-8 hours (Greer, 2005).
Vigilant nursing assessment is critical since patient status can change rapidly during the
induction phase. Nurses should monitor for signs of shivering such as increased respiratory rate
and muscle tensing of chest or facial muscles. Other signs of shivering may include a reduction
in venous oxygen saturation and a static tracing on the ECG (Mahmood & Zweifler, 2007).
Endotracheal intubation and mechanical ventilation may need to be established, requiring
administration of opiates, paralytics, and neuromuscular blockers for providing patient comfort
and enhancing therapeutic benefits (Mahmood & Zweifler, 2007). Bispectral index monitoring
helps ensure optimal sedation and reduces the risk of oversedation.
During the induction phase vital signs should be closely monitored. Arterial lines
facilitate continuous blood pressure monitoring. A systolic blood pressure greater that 90 mm Hg
and mean arterial pressure (MAP) of greater than 80 mm Hg is desirable during IH (Greer,
2005). Temperature monitoring may be obtained via pulmonary artery temperature probes or
bladder temperature probes. ECG monitoring with attention toward bradycardia should be
performed. A secondary temperature monitoring device may be advised in patients with bladder
probes, since the reading of core body temperature is dependent on adequate urine output (Greer,
2005).
Measures should be taken early to reduce patients’ risk for infection. If tolerated, the head
of the patient’s bed should be elevated between 30°-45°. Suctioning secretions and providing
oral hygiene are important aspects of nursing care to reduce the risk for pneumonia (Sole, Klein,
& Moseley, 2009). White blood cell (WBC) count should be monitored. Skin care and frequent
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turning help maintain skin integrity (McKean, 2009). If surface cooling methods are used, skin
should be assessed every 2-6 hours for thermal injury (Bessman, Talavera, Setnik, Halamka, &
Alder, 2010). Additional protective measures include antibiotic prophylaxis and antibiotic
decontamination of the gastrointestinal tract (Polderman, 2004).
Fluid and electrolyte shifts begin during the induction phase. Hemodynamic monitoring
and fluid replacement should be established at the beginning of treatment. Chemistry panels,
CBC, and blood glucose levels should be obtained at 0, 12, and 24 hours. Blood cultures and
ABG measurements are also recommended at 12 hour intervals (Greer, 2005).
Ongoing assessment should continue during the hypothermic period. During the
hypothermic period each of the above functions requires close assessment. In addition to the
assessments performed during the induction phase, timely monitoring and replacement of
electrolytes are essential to prevent further complications. Potassium levels are of specific
concern and need to be frequently assessed (Finkelstein & Alam, 2010). Medication
administration for hypothermic patients may require lower than normal doses due to
hypometabolism. Standard dosing schedules may lead to plasma drug accumulation and toxicity.
Critical care nurses need to be cognizant of this potential effect and monitor for adverse effects
of drug toxicity such as respirator depression and changes in heart rate or blood pressure (Lewis
et al., 2007).
The rewarming phase may be passive or controlled. Passive rewarming involves the
removal of cooling devices such as blankets or ice packs. Controlled rewarming is achieved by
programming a cooling device such as the Arctic Sun or Cool Guard to the desired warming rate.
For either method, the recommended rate of warming is 0.3°-1.0°C every hour until core body
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temperature returns to 36°C. In general, normothermia should be achieved within 6-8 hours
(Bessman et al., 2010).
During rewarming, the risk increases for rebound hyperkalemia, hyperthermia,
hyperglycemia, and hypotension (McKean, 2009; Polderman & Ingeborg, 2009). Rewarming
may be the most critical phase of IH as therapeutic effects may be reversed if complications and
patient condition are poorly managed (Greer, 2005). The use of sedation and paralytics should
continue until the patient achieves target, normothermic core body temperature. Medication
doses may need to be adjusted as metabolism increases (Polderman & Ingeborg, 2009).
Nursing Education and Research
Efficacy of treatment is largely dependent on early implementation of IH in patients
meeting criteria for treatment. Nurses should be trained in identification of patients who may
benefit from IH to promote early intervention. The variety of complications associated with IH
requires proficiency in nursing care. Continuing education on methods for inducing hypothermia
and the associated interventions that may be required to maintain patient stability can play a vital
role in preparing nurses to manage patient care.
Additional research needs to be conducted to assess therapeutic benefits in populations
where clinical trials are lacking, including head trauma, stroke, and spinal cord injury. Specific
focus on management of complications should be addressed to promote development of
recommendations for best practice. Rather than focusing on complications in general, it may be
beneficial to conduct research studies addressing individual complications.
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Summary
Hypothermia is documented to improve outcomes following anoxic brain injury, cardiac
arrest, and stroke. As exploration in this field advances, IH is being considered to treat specific
cases of traumatic head injury, bacterial meningitis, spinal cord injury, and hepatic
encephalopathy. Animal studies are well-documented and show promising results. Human
clinical trials, however, are limited and small in number with variable quality. Results of clinical
trials show varying support for IH, and further research needs to be conducted to validate these
findings. Studies to date show correlations between IH and physiological complications. As
future studies are performed, medical personnel need to be informed of these adverse effects, so
care is properly managed and therapeutic benefits are maximized.
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APPENDIX: Table of Evidence
Author / Year
/ Title
Bernard &
Buist, 2003

Population
Studied
Anoxic brain
injury
following
cardiac arrest,
traumatic head
injury, stroke,
hepatic encephalopathy,
encephalitis,
bacterial
meningitis,
ARDS, HF,
and
postoperative
tachycardia

Complications
Evaluated
CNS, acidbase balance,
electrolytes,
and cardiovascular,
respiratory,
renal, GI, and
hematologic
systems

Compare
outcomes in
patients
Lack of effect
treated with
of induction of IH and those
hypothothermia who received
after acute
standard
brain injury
treatment

Comatose
following
closed head
injury

Fluid and
electrolyte
balance, lab
value
alterations, and
hypotension

Finkelstein &
Alam, 2010

Trauma with or
without cardiac
arrest,
traumatic brain
injury, spinal
cord injury,
and blunt
trauma

Increased
infections,
coagulopathy,
hemodynamic
effects,
dysrhythmias,
alterations in
drug
metabolism,
and fluid,

Induced
hypothermia in
critical care
medicine: A
review

Study /
Purpose
Review IH as
a treatment
option for
patients with
neurologic
disorders

Clifton et al.,
2001

Induced
hypothermia
for trauma

Discuss
potential
benefits and
complications
of IH in the
trauma
population,
including
penetrating
trauma with
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Results /
Findings
Improved
outcomes in two
trials in patients
with anoxic
brain injury
following
cardiac arrest
Variable results
in patients with
severe head
injury
Promising
results in
preliminary
clinical trials of
the use of IH
with stroke,
neurologic
infection, and
hepatic
encephalopathy
Comparable
outcomes and
mortality rates
between to
those receiving
IH and those
treated with
standard
interventions

Conclusion /
Implications
ICU patients
meeting
specific
criteria should
be considered
for IH. Critical
care
physicians
should be
knowledgeable in
terms of
physiologic
effects of IH,
methods of
inducing IH,
and potential
complications.

Results were
inconclusive.

IH is not
effective in
improving
outcomes in
patients with
severe brain
injury.
Uniform efficacy Further study
seen in
needed in SCI
preclinical trials and blunt
with penetrating trauma; IH
trauma with
beneficial with
cardiac arrest,
other types of
delaying cardiac trauma,
arrest in trauma
specifically
patients who are penetrating
hypotensive, and trauma with

Author / Year
/ Title

Kuffler, 2010

Study /
Purpose
cardiac arrest;
evaluate the
role of IH in
delaying
cardiac arrest
in
hypotensive
patients with
penetrating
trauma, and
traumatic
brain injury
Neuroprotection
provided by
hypothermia

Combinatorial
techniques for
enhancing
neuroprotection Combining
IH with other
therapies and
treatments
McKean, 2009 Overview of
the pathoInduced
physiology of
moderate
cerebral
hypothermia
ischemia and
after cardiac
physiologic
arrest
changes
associated
with IH.

Overview of
the history
and
research of IH
following
cardiac arrest.

Population
Studied

Complications
Evaluated
electrolyte, and
metabolic
disturbances

Results /
Findings
traumatic brain
injury

Conclusion /
Implications
cardiac arrest

Conflicting
results between
preclinical and
clinical trials in
traumatic brain
injury patients

Variety of
neuronal
insults

Inclusion
criteria:
Comatose
following
cardiac arrest
Exclusion
criteria:
Patients with
lifethreatenting
arrhythmias,
primary
coagulopathy,
pregnancy, and
sepsis

Treatment of
complications
with neurotrophins, antiinflammatory
agents,
immunetherapy, and
alkalinization
Prevention of
shivering, VS
monitoring,
skin care
issues, fluid
and electrolyte
imbalances,
lab value
monitoring,
prevention of
infection, and
rewarming

Nursing
management
considerations
for patients
with IH and
consideration
of IH protocol
development.
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Survival rates
and neurologic
outcomes are
significantly
improved by
whole body
hypothermia

55% of patients
with IH had
favorable
outcomes

Effective
neuroprotection
possible when
multiple
treatments are
implemented
simultaneously.
IH is
beneficial
following
cardiac arrest,
but
implementtation has been
slow.
Additional
protocols
including
detailed
instructions
need to be
developed to
encourage
consistent and
safe
implementtation of IH.

Author / Year
/ Title
Oddo, Schaller,
Feihl, Ribordy,
& Liaudet,
2006
From evidence
to clinical
practice:
Effective
implementation
of therapeutic
hypothermia to
improve patient
outcome after
cardiac arrest
Polderman,
2004

Study /
Purpose
Evaluate the
use of IH in
the ICU and
whether IH
improves
outcomes of
all comatose
patients with
cardiac arrest

Population
Studied
Comatose
following outof-hospital
cardiac arrest

Evaluate the
benefits and
risks of IH

Variety of
neurological
injuries

Determine if
the use of IH
is beneficial
in reducing
the risk of
death or
severe
disability in
head trauma
patients.

Closed
traumatic head
injury

Hypothermia
for traumatic
head injury

Conclusion /
Implications
IH can be
successfully
implemented
in the ICU and
is beneficial to
patients in
cardiac arrest
and shock.

Poor outcomes
in patients with
nonventricular
dysrhythmias

Application of
therapeutic
hypothermia in
the intensive
care unit

Sydenham,
Roberts &
Alderson, 2009

Complications Results /
Evaluated
Findings
IH had a positive
impact on the
outcome of
patients in
ventricular
fibrillation and
shock.

Cardiovascular
and
hemodynamic
effects,
coagulopathies,
infection,
hypovolemia,
fluid and
electrolyte
imbalances,
other
metabolic
effects,
shivering, drug
metabolism
Pneumonia,
unfavorable
outcomes
including
vegetative
state and
severe
disability

Determine if
IH places
patients at
risk for
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IH useful in
preventing or
limiting damage
to an injured
brain or spinal
cord

Successful
application of
IH requires
vigilant care
and team
effort.

Results were not
statistically
significant.

No evidence
that IH is
beneficial in
cases of head
injury.
IH may help
reduce the
occurrence of
death, but
significant
benefit was
only found in
low quality
trials.

Author / Year
/ Title

Study /
Purpose
pneumonia.

Population
Studied

Complications Results /
Evaluated
Findings

High quality
trials found no
decreased risk
of death with
IH

Estimate the
effects of IH
on mortality
and long-term
functional
outcomes in
patients with
traumatic
head injury

Zeitzer, 2005
Inducing
hypothermia to
decrease
neurological
deficit:
literature
review

Determine if
IH reduces
the number of
patients at the
follow-up
period who
experienced
unfavorable
outcomes or
death
Examine the
effectiveness
of IH to
decrease
neurological
deficit

Out-ofhospital,
witnessed
cardiac arrest

Sepsis,
coagulopathies,
neutropenia,
thrombocytopenia,
arrhythmias,
and electrolyte
abnormalities

Six studies
showed
improved
outcomes
Four showed
decreased
mortality
Minimal
complications
exist

Zhi, Zhang &
Lin, 2003
Study on
therapeutic
mechanism and
clinical effect
of mild
hypothermia in
patients with
severe head

Patients with
acute head
injury within
24 hrs of
trauma with
major organ
damage or
functional
failure
without
hypotension

Conclusion /
Implications

Severe head
injury with a
GCS of <8
upon admission
to the ED

Effects on ICP,
blood glucose
and lactic acid,
vital sign
changes,
namely blood
pressure and
heart rate,
blood gases,
and
electrolytes
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IH is safe and
effective for
preventing brain
damage,
reducing
mortality, and
improving the
prognosis in
patients with
severe head
injury.

Advanced
practice nurses
should
promote the
use of IH.
Further
research
should be
conducted on
specific
treatment
protocols.
IH reduced
mortality and
improved
outcomes in
patients whose
treatment
included IH.
IH decreased
ICP, lactic
acid levels and

Author / Year
/ Title
injury

Study /
Purpose

Population
Studied

Complications Results /
Evaluated
Findings

Conclusion /
Implications
hyperglycemia and
improved
cerebral blood
flow.
No significant
changes in
vital signs,
blood gas
values, and
electrolytes
occurred in the
IH group.
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